Bayer

143 results

Ger Brennan, who trained as a nurse, was keen to merge his medical interest with sales. After ‘a hundred PFOs’ applying to be a medical rep he landed a contract job with Bayer

Brexit doesn’t worry Ger Brennan. It’s a startling take from an industry leader, given how much the relentless uncertainty over the manner of the even(...)

NYSE: White House economic adviser Larry Kudlow calmed market nerves over  outcome of trade talks with China later in  week. Photograph:  Johannes Eisele/AFP via Getty

European markets rose on Monday as the aviation and chemicals industries gained ground, but Brexit woes hit British building-related stocks. DUBLIN (...)

Glyphosate is cleared for use in the EU until December 2022. Photograph: iStock

Ireland is unlikely to follow Germany and other EU countries in banning use of the weed killer glyphosate– the subject of billion-dollar US lawsuits o(...)

Concerns about glyphosate emerged when a World Health Organisation agency concluded in 2015 that it probably causes cancer

The German government will ban the use of controversial weedkiller glyphosate - the subject of US lawsuits over claims it causes cancer - from the end(...)

‘Overall, we have registered a decrease in new live and potential campaigns compared to the first half of 2018,’ said William Mace, assistant editor at ActivistMonitor

Demands made by prominent shareholders in listed European companies fell in the first half this year, a possible result of slowdown in growth of the g(...)

New York: Wall Street’s main indexes added to losses on Friday. Photograph: Brendan McDermid/Reuters

European shares slid on Friday with Italian stocks 2.5 per cent lower on political uncertainty, while comments by US president Donald Trump that he wa(...)

German drugmaker Bayer. It said last year it would lean more strongly on external firms and institutions to jump start its development pipeline. Photograph: Getty Images

German drugmaker Bayer is paying up to $600 million (€535m) for full control of cell therapy developer BlueRock Therapeutics, stepping up investment i(...)

Chemical companies Bayer and Lanxess are selling their shares in chemical park operator Currenta to funds managed by  Macquarie Infrastructure and Real Assets. Photograph: EPA

European shares rose on Wednesday, breaking a three-day losing streak on euphoria over a multi-billion dollar German chemical deal, with Flutter Enter(...)

Dr Scholl’s was founded more than 110 years ago, and recorded sales of $234 million last year.

Bayer has agreed to sell its Dr Scholl’s footcare business to private equity group Yellow Wood Partners for $585 million (€522 million), the latest in(...)

Ryanair closed down over 5 per cent lower in Dublin

German shares drove Europe lower on Tuesday after a profit warning from chemicals giant BASF citing trade friction put chemical and auto makers on the(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »